Home » Topics » BioWorld Science

BioWorld Science
RSS

Takhzyro subcutaneous injection approved in Europe for the preventive treatment of HAE

Nov. 30, 2018

Phase III clinical study of Fycompa monotherapy meets primary endpoint

Nov. 30, 2018

Forge Therapeutics presents bacterial lpxC inhibitors

Nov. 30, 2018

KCNQ2/3 channel activators patented by Knopp Biosciences

Nov. 30, 2018

Genetics of ADHD correlates with health risk behavior

Nov. 30, 2018

The Warner Babcock Institute for Green Chemistry patents beta-amyloid inhibitors

Nov. 30, 2018

Positive preliminary phase I data presented for TransCon CNP

Nov. 30, 2018

Transitional endoplasmic reticulum ATPase inhibitors identified at the University of Pittsburgh

Nov. 30, 2018

Takeda describes new BRD4 BD2 domain inhibitors

Nov. 30, 2018

Phase I results reported for EBV-specific T-cell therapy in progressive multiple sclerosis

Nov. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...